CoChat

Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction?

Open access
Keshavarz, Maryam, Xie, Kan, Schaaf, Kristina, Bano, Daniele, Ehninger, Dan · 2023 · Molecular Psychiatry
Cited by 118

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Aging is a major risk factor for a number of chronic diseases, including neurodegenerative and cerebrovascular disorders. Aging processes have therefore been discussed as potential targets for the development of novel and broadly effective preventatives or therapeutics for age-related diseases, including those affecting the brain. Mechanisms thought to contribute to aging have been summarized under the term the “hallmarks of aging” and include a loss of proteostasis, mitochondrial dysfunction, altered nutrient sensing, telomere attrition, genomic instability, cellular senescence, stem cell exhaustion, epigenetic alterations and altered intercellular communication. We here examine key claims about the “hallmarks of aging”. Our analysis reveals important weaknesses that preclude strong and definitive conclusions concerning a possible role of these processes in shaping organismal aging rate. Significant ambiguity arises from the overreliance on lifespan as a proxy marker for aging, the use of models with unclear relevance for organismal aging, and the use of study designs that do not allow to properly estimate intervention effects on aging rate. We also discuss future research directions that should be taken to clarify if and to what extent putative aging regulators do in fact interact with aging. These include multidimensional analytical frameworks as well as designs that facilitate the proper assessment of intervention effects on aging rate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-022-01680-x

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 177

  1. Castillo X, Castro-Obregón S, Gutiérrez-Becker B, Gutiérrez-Ospina G, Karalis N, Khalil AA et al. Re-thinking the etiological framework of neurodegeneration. Front Neurosci. 2019;13. https://doi.org/10.3389/fnins.2019.00728. · DOI · Paper page
  2. Kaeberlein M, Galvan V, Rapamycin and Alzheimer’s disease: Time for a clinical trial? Sci Transl Med. 2019;11. https://doi.org/10.1126/scitranslmed.aar4289. · DOI · Paper page
  3. Daniele S, Giacomelli C, Martini C. Brain ageing and neurodegenerative disease: The role of cellular waste management. Biochem Pharmacol. 2018;158:207–16. · DOI · Paper page
  4. Miller RA Biology of Aging and Longevity. In: Halter JB, Ouslander JG, Tinetti ME, Studenski S, High KP, Asthana S (eds). Hazzard’s Geriatric Medicine and Gerontology, 6th edition edn. McGraw Hill 2009.
  5. Zhang R, Chen HZ, Liu DP. The four layers of aging. Cell Syst. 2015;1:180–6. · DOI
  6. Gems D, de Magalhães JP. The hoverfly and the wasp: A critique of the hallmarks of aging as a paradigm. Ageing Res Rev. 2021;70:101407. · DOI · Paper page
  7. Lemoine M. The evolution of the hallmarks of aging. Front Genet. 2021;12:693071. · DOI
  8. van der Rijt S, Molenaars M, McIntyre RL, Janssens GE, Houtkooper RH. Integrating the hallmarks of aging throughout the tree of life: a focus on mitochondrial dysfunction. Front Cell Dev Biol. 2020;8:594416. · DOI · Paper page
  9. Aunan JR, Cho WC, Søreide K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis. 2017;8:628–42. · DOI · Paper page
  10. Chmielewski PP. Human ageing as a dynamic, emergent and malleable process: from disease-oriented to health-oriented approaches. Biogerontology. 2020;21:125–30. · DOI
  11. Guimarães GR, Almeida PP, de Oliveira Santos L, Rodrigues LP, de Carvalho JL, Boroni M, Hallmarks of aging in macrophages: consequences to skin inflammaging. Cells 2021;10. https://doi.org/10.3390/cells10061323. · DOI
  12. Sun Y, Liu Y, Ma X, Hu H. The influence of cell cycle regulation on chemotherapy. Int J Mol Sci. 2021;22:6923. · DOI · Paper page
  13. Yao Y, Dai W. Genomic instability and cancer. J Carcinog Mutagen. 2014;5:1000165.
  14. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. · DOI · Paper page
  15. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. · DOI · Paper page
  16. Pettan-Brewer C, Treuting PM Practical pathology of aging mice. Pathobiol Aging Age Relat Dis. 2011;1. https://doi.org/10.3402/pba.v1i0.7202. · DOI
  17. Lipman R, Galecki A, Burke DT, Miller RA. Genetic loci that influence cause of death in a heterogeneous mouse stock. J Gerontol A Biol Sci Med Sci. 2004;59:977–83. · DOI · Paper page
  18. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66:191–201. · DOI · Paper page
  19. Xie K, Neff F, Markert A, Rozman J, Aguilar-Pimentel JA, Amarie OV, et al. Every-other-day feeding extends lifespan but fails to delay many symptoms of aging in mice. Nat Commun. 2017;8:155. · DOI · Paper page
  20. Baker DJ, Dawlaty MM, Wijshake T, Jeganathan KB, Malureanu L, van Ree JH, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2013;15:96–102. · DOI · Paper page
  21. Weaver RL, Limzerwala JF, Naylor RM, Jeganathan KB, Baker DJ, van Deursen JM, BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer. Elife 2016;5. https://doi.org/10.7554/eLife.16620. · DOI
  22. Ehninger D, Neff F, Xie K. Longevity, aging and rapamycin. Cell Mol Life Sci. 2014;71:4325–46. · DOI · Paper page
  23. Liu M, Howes A, Lesperance J, Stallcup WB, Hauser CA, Kadoya K, et al. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Cancer Res. 2005;65:5325–36. · DOI · Paper page
  24. Woo Y, Lee HJ, Kim J, Kang SG, Moon S, Han JA, et al. Rapamycin promotes ROS-mediated cell death via functional inhibition of xCT expression in melanoma under γ-irradiation. Front Oncol. 2021;11:665420. · DOI
  25. Xing D, Orsulic S. A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proc Natl Acad Sci USA. 2005;102:6936–41. · DOI · Paper page
  26. Amaral CL, Freitas LB, Tamura RE, Tavares MR, Pavan IC, Bajgelman MC, et al. S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells. BMC Cancer. 2016;16:602. · DOI
  27. Lee S, Roh HS, Song SS, Shin J, Lee J, Bhang DH, et al. Loss of S6K1 but Not S6K2 in the tumor microenvironment suppresses tumor growth by attenuating tumor angiogenesis. Transl Oncol. 2020;13:100767. · DOI
  28. Lai KP, Cheung A, Ho CH, Tam NY, Li JW, Lin X, et al. Transcriptomic analysis reveals the oncogenic role of S6K1 in hepatocellular carcinoma. J Cancer. 2020;11:2645–55. · DOI
  29. Song X, Han X, Yu F, Zhang X, Chen L, Lv C. Polyamine-targeting Gefitinib Prodrug and its near-infrared fluorescent theranostic derivative for monitoring drug delivery and lung cancer therapy. Theranostics. 2018;8:2217–28. · DOI
  30. Thomas TJ, Thomas T, Cellular and animal model studies on the growth inhibitory effects of polyamine analogues on breast cancer. Med Sci. 2018;6. https://doi.org/10.3390/medsci6010024. · doi:10.3390/medsci6010024
  31. Chen Y, Zhuang H, Chen X, Shi Z, Wang X. Spermidine‑induced growth inhibition and apoptosis via autophagic activation in cervical cancer. Oncol Rep. 2018;39:2845–54.
  32. Boguszewski CL, Boguszewski M. Growth hormone’s links to cancer. Endocr Rev. 2019;40:558–74. · DOI · Paper page
  33. Chhabra Y, Waters MJ, Brooks AJ. Role of the growth hormone-IGF-1 axis in cancer. Expert Rev Endocrinol Metab. 2011;6:71–84. · DOI
  34. Takei Y, Saga Y, Mizukami H, Takayama T, Ohwada M, Ozawa K, et al. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol Cancer Ther. 2008;7:704–11. · DOI
  35. Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell. 2012;149:49–62. · DOI · Paper page
  36. Saga Y, Mizukami H, Suzuki M, Kohno T, Urabe M, Ozawa K, et al. Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells. Clin Cancer Res. 2002;8:1248–52.
  37. Li B, Zhang J, Su Y, Hou Y, Wang Z, Zhao L, et al. Overexpression of PTEN may increase the effect of pemetrexed on A549 cells via inhibition of the PI3K/AKT/mTOR pathway and carbohydrate metabolism. Mol Med Rep. 2019;20:3793–801.
  38. Liu N, Rowley BR, Bull CO, Schneider C, Haegebarth A, Schatz CA, et al. BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models. Mol Cancer Ther. 2013;12:2319–30. · DOI · Paper page
  39. Soler A, Serra H, Pearce W, Angulo A, Guillermet-Guibert J, Friedman LS, et al. Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. J Exp Med. 2013;210:1937–45. · DOI · Paper page
  40. Soler A, Figueiredo AM, Castel P, Martin L, Monelli E, Angulo-Urarte A, et al. Therapeutic benefit of selective inhibition of p110α PI3-Kinase in pancreatic neuroendocrine tumors. Clin Cancer Res. 2016;22:5805–17. · DOI
  41. Goulielmaki E, Bermudez-Brito M, Andreou M, Tzenaki N, Tzardi M, de Bree E, et al. Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages. Cell Death Dis. 2018;9:678. · DOI
  42. deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, et al. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. Clin Cancer Res. 2004;10:8059–67. · DOI · Paper page
  43. Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc Natl Acad Sci USA. 2001;98:10320–5. · DOI · Paper page
  44. Srivastava RK, Li C, Khan J, Banerjee NS, Chow LT, Athar M. Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells. Proc Natl Acad Sci USA. 2019;116:24583–92. · DOI
  45. Anisimov VN. Metformin for aging and cancer prevention. Aging. 2010;2:760–74. · DOI
  46. Chang HH, Moro A, Chou CEN, Dawson DW, French S, Schmidt AI, et al. Metformin decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity in the conditional KrasG12D Mouse model. Sci Rep. 2018;8:5899. · DOI
  47. Chen K, Qian W, Jiang Z, Cheng L, Li J, Sun L, et al. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol Cancer. 2017;16:131. · DOI · Paper page
  48. Aljofan M, Riethmacher D. Anticancer activity of metformin: a systematic review of the literature. Future Sci OA. 2019;5:Fso410. · DOI · Paper page
  49. Pallavi R, Giorgio M, Pelicci PG. Insights into the beneficial effect of caloric/dietary restriction for a healthy and prolonged life. Front Physiol. 2012;3:318. · DOI
  50. Morioka T, Yamazaki S, Yanagihara H, Sunaoshi M, Kaminishi M, Kakinuma S. Calorie restriction suppresses the progression of radiation-induced intestinal tumours in C3B6F1 Apc (Min/+) Mice. Anticancer Res. 2021;41:1365–75. · DOI
  51. Kopeina GS, Senichkin VV, Zhivotovsky B. Caloric restriction—A promising anti-cancer approach: From molecular mechanisms to clinical trials. Biochim Biophys Acta Rev Cancer. 2017;1867:29–41. · DOI
  52. Gates AC, Bernal-Mizrachi C, Chinault SL, Feng C, Schneider JG, Coleman T, et al. Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. Cell Metab. 2007;6:497–505. · DOI · Paper page
  53. Shrestha R, Johnson E, Byrne FL. Exploring the therapeutic potential of mitochondrial uncouplers in cancer. Mol Metab. 2021;51:101222. · DOI · Paper page
  54. Matheu A, Maraver A, Collado M, Garcia-Cao I, Cañamero M, Borras C, et al. Anti-aging activity of the Ink4/Arf locus. Aging Cell. 2009;8:152–61. · DOI · Paper page
  55. Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Clin Cancer Res. 2001;7:1765–72.
  56. Zhou X, Singh M, Sanz Santos G, Guerlavais V, Carvajal LA, Aivado M, et al. Pharmacological activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting anti-tumor immunity. Cancer Discov. 2021;11:3090–105. https://doi.org/10.1158/2159-8290.CD-20-1741. · DOI · Paper page
  57. Ramos H, Soares MIL, Silva J, Raimundo L, Calheiros J, Gomes C, et al. A selective p53 activator and anticancer agent to improve colorectal cancer therapy. Cell Rep. 2021;35:108982. · DOI
  58. Wang Z, Sun Y. Targeting p53 for novel anticancer therapy. Transl Oncol. 2010;3:1–12. · DOI · Paper page
  59. Rohwer N, Kühl AA, Ostermann AI, Hartung NM, Schebb NH, Zopf D, et al. Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis. Cancer Med. 2020;9:2535–50. · DOI
  60. Guillem-Llobat P, Dovizio M, Bruno A, Ricciotti E, Cufino V, Sacco A, et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget. 2016;7:32462–77. · DOI · Paper page
  61. Li XF, Xu BZ, Wang SZ. Aspirin inhibits the proliferation and migration of gastric cancer cells in p53-knockout mice. Oncol Lett. 2016;12:3183–6. · doi:10.3892/ol.2016.5067
  62. Yang C, Liu J, Wang Y, Tong J, Wu Y, Liu Y. Aspirin inhibits the proliferation of canine mammary gland tumor cells in vitro and in vivo. Transl Cancer Res. 2017;6:188–97. · doi:10.21037/tcr.2017.01.07
  63. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702–17. · DOI
  64. Van Dyke T, Jacks T. Cancer modeling in the modern era: progress and challenges. Cell. 2002;108:135–44. · DOI · Paper page
  65. Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer. 2007;7:645–58. · DOI · Paper page
  66. Becher OJ, Holland EC. Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res. 2006;66:3355–8. discussion 3358-9 · DOI · Paper page
  67. Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci USA. 2012;109:21528–33. · DOI · Paper page
  68. Rera M, Clark RI, Walker DW. Why do old flies die? Aging. 2013;5:586–7. · DOI
  69. Biteau B, Karpac J, Supoyo S, Degennaro M, Lehmann R, Jasper H. Lifespan extension by preserving proliferative homeostasis in Drosophila. PLoS Genet. 2010;6:e1001159. · DOI · Paper page
  70. Wang L, Karpac J, Jasper H. Promoting longevity by maintaining metabolic and proliferative homeostasis. J Exp Biol. 2014;217:109–18. · DOI
  71. Rera M, Azizi MJ, Walker DW. Organ-specific mediation of lifespan extension: more than a gut feeling? Ageing Res Rev. 2013;12:436–44. · DOI · Paper page
  72. Choi NH, Kim JG, Yang DJ, Kim YS, Yoo MA. Age-related changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging Cell. 2008;7:318–34. · DOI · Paper page
  73. Regan JC, Khericha M, Dobson AJ, Bolukbasi E, Rattanavirotkul N, Partridge L. Sex difference in pathology of the ageing gut mediates the greater response of female lifespan to dietary restriction. Elife. 2016;5:e10956. · DOI · Paper page
  74. Fan X, Liang Q, Lian T, Wu Q, Gaur U, Li D, et al. Rapamycin preserves gut homeostasis during Drosophila aging. Oncotarget. 2015;6:35274–83. · DOI
  75. Rodriguez-Fernandez IA, Tauc HM, Jasper H. Hallmarks of aging Drosophila intestinal stem cells. Mech Ageing Dev. 2020;190:111285. · DOI
  76. Choi NH, Lucchetta E, Ohlstein B. Nonautonomous regulation of Drosophila midgut stem cell proliferation by the insulin-signaling pathway. Proc Natl Acad Sci USA. 2011;108:18702–7. · DOI
  77. Wang L, Ryoo HD, Qi Y, Jasper H. PERK limits drosophila lifespan by promoting intestinal stem cell proliferation in response to ER stress. PLoS Genet. 2015;11:e1005220. · DOI
  78. Paredes JC, Welchman DP, Poidevin M, Lemaitre B. Negative regulation by amidase PGRPs shapes the Drosophila antibacterial response and protects the fly from innocuous infection. Immunity. 2011;35:770–9. · DOI · Paper page
  79. Hu DJ-K, Jasper H. Control of intestinal cell fate by dynamic mitotic spindle repositioning influences epithelial homeostasis and longevity. Cell Rep. 2019;28:2807–23.e2805. · DOI
  80. Guo L, Karpac J, Tran Susan L, Jasper H. PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell. 2014;156:109–22. · DOI · Paper page
  81. Salazar AM, Resnik-Docampo M, Ulgherait M, Clark RI, Shirasu-Hiza M, Jones DL, et al. Intestinal Snakeskin limits microbial dysbiosis during aging and promotes longevity. iScience. 2018;9:229–43. · DOI
  82. Hwangbo DS, Gershman B, Tu MP, Palmer M, Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature. 2004;429:562–6. · DOI · Paper page
  83. Broughton SJ, Piper MD, Ikeya T, Bass TM, Jacobson J, Driege Y, et al. Longer lifespan, altered metabolism, and stress resistance in Drosophila from ablation of cells making insulin-like ligands. Proc Natl Acad Sci USA. 2005;102:3105–10. · DOI · Paper page
  84. Libert S, Zwiener J, Chu X, Vanvoorhies W, Roman G, Pletcher SD. Regulation of Drosophila life span by olfaction and food-derived odors. Science. 2007;315:1133–7. · DOI · Paper page
  85. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010;11:35–46. · DOI · Paper page
  86. Fridell YW, Hoh M, Kréneisz O, Hosier S, Chang C, Scantling D, et al. Increased uncoupling protein (UCP) activity in Drosophila insulin-producing neurons attenuates insulin signaling and extends lifespan. Aging. 2009;1:699–713. · DOI · Paper page
  87. Magwere T, Chapman T, Partridge L. Sex differences in the effect of dietary restriction on life span and mortality rates in female and male Drosophila melanogaster. J Gerontol A Biol Sci Med Sci. 2004;59:3–9. · DOI · Paper page
  88. Owusu-Ansah E, Song W, Perrimon N. Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell. 2013;155:699–712. · DOI · Paper page
  89. Giannakou ME, Goss M, Jünger MA, Hafen E, Leevers SJ, Partridge L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science. 2004;305:361. · DOI · Paper page
  90. Rallis A, Navarro JA, Rass M, Hu A, Birman S, Schneuwly S, et al. Hedgehog signaling modulates glial proteostasis and lifespan. Cell Rep. 2020;30:2627–43.e2625. · DOI
  91. Wang MC, Bohmann D, Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell. 2005;121:115–25. · DOI · Paper page
  92. Broughton SJ, Slack C, Alic N, Metaxakis A, Bass TM, Driege Y, et al. DILP-producing median neurosecretory cells in the Drosophila brain mediate the response of lifespan to nutrition. Aging Cell. 2010;9:336–46. · DOI · Paper page
  93. Chen H, Zheng X, Zheng Y. Age-associated loss of lamin-B leads to systemic inflammation and gut hyperplasia. Cell. 2014;159:829–43. · DOI · Paper page
  94. Ayyaz A, Li H, Jasper H. Haemocytes control stem cell activity in the Drosophila intestine. Nat Cell Biol. 2015;17:736–48. · DOI
  95. Han H, Pan C, Liu C, Lv X, Yang X, Xiong Y, et al. Gut–neuron interaction via Hh signaling regulates intestinal progenitor cell differentiation in Drosophila. Cell Discov. 2015;1:15006. · DOI
  96. Huang C, Xiong C, Kornfeld K. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc Natl Acad Sci USA. 2004;101:8084–9. · DOI · Paper page
  97. Zhao Y, Gilliat AF, Ziehm M, Turmaine M, Wang H, Ezcurra M, et al. Two forms of death in ageing Caenorhabditis elegans. Nat Commun. 2017;8:15458. · DOI
  98. Zhao Y, Zhang B, Marcu I, Athar F, Wang H, Galimov ER, et al. Mutation of daf-2 extends lifespan via tissue-specific effectors that suppress distinct life-limiting pathologies. Aging Cell. 2021;20:e13324–e13324. · DOI
  99. Zhao Y, Wang H, Poole RJ, Gems D. A fln-2 mutation affects lethal pathology and lifespan in C. elegans. Nat Commun. 2019;10:5087. · DOI
  100. Sahin M. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr Opin Neurobiol. 2012;22:895–901. · DOI
  101. Crino PB. Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol. 2013;125:317–32. · DOI
  102. Crowell B, Lee GH, Nikolaeva I, Dal Pozzo V, D’Arcangelo G, Complex neurological phenotype in mutant mice lacking Tsc2 in excitatory neurons of the developing forebrain(123). eNeuro 2015;2. · DOI
  103. Chen L, Oshima J. Werner Syndrome. J Biomed Biotechnol. 2002;2:46–54. · DOI · Paper page
  104. Lombard DB, Miller RA, Pletcher SD, Biology of Aging and Longevity. In: Halter JB, Ouslander JG, Studenski S, High KP, Asthana S, Supiano MA et al. (eds). Hazzard’s Geriatric Medicine and Gerontology, 7e. McGraw-Hill Education: New York, NY, 2017.
  105. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300. · DOI · Paper page
  106. McDonald RB “Cellular Aging” in Biology of Aging second edition, CRC Press 2019. · doi:10.1201/9780429030642
  107. Harman D. The free radical theory of aging: effect of age on serum copper levels. J Gerontol. 1965;20:151–3. · DOI · Paper page
  108. Doonan R, McElwee JJ, Matthijssens F, Walker GA, Houthoofd K, Back P, et al. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008;22:3236–41. · DOI · Paper page
  109. Mesquita A, Weinberger M, Silva A, Sampaio-Marques B, Almeida B, Leão C, et al. Caloric restriction or catalase inactivation extends yeast chronological lifespan by inducing H2O2 and superoxide dismutase activity. Proc Natl Acad Sci USA. 2010;107:15123–8. · DOI · Paper page
  110. Zhang Y, Ikeno Y, Qi W, Chaudhuri A, Li Y, Bokov A, et al. Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci. 2009;64:1212–20. · DOI · Paper page
  111. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol. 1992;27:375–82. · DOI · Paper page
  112. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res. 1991;256:271–82. · DOI · Paper page
  113. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992;89:10114–8. · DOI · Paper page
  114. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–36. · DOI · Paper page
  115. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 1990;249:1129–33. · DOI · Paper page
  116. Hemann MT, Greider CW. Wild-derived inbred mouse strains have short telomeres. Nucleic Acids Res. 2000;28:4474–8. · DOI · Paper page
  117. Calado RT, Dumitriu B. Telomere dynamics in mice and humans. Semin Hematol. 2013;50:165–74. · DOI · Paper page
  118. Simons MJ. Questioning causal involvement of telomeres in aging. Ageing Res Rev. 2015;24:191–6. · DOI · Paper page
  119. Muñoz-Lorente MA, Cano-Martin AC, Blasco MA. Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Nat Commun. 2019;10:4723. · DOI · Paper page
  120. Qi L, Strong MA, Karim BO, Armanios M, Huso DL, Greider CW. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res. 2003;63:8188–96.
  121. Feldser DM, Greider CW. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell. 2007;11:461–9. · DOI · Paper page
  122. Hahn WC, Meyerson M. Telomerase activation, cellular immortalization and cancer. Ann Med. 2001;33:123–9. · DOI · Paper page
  123. Yakoub AM. Cerebral organoids exhibit mature neurons and astrocytes and recapitulate electrophysiological activity of the human brain. Neural Regen Res. 2019;14:757–61. · DOI
  124. Rambani K, Vukasinovic J, Glezer A, Potter SM. Culturing thick brain slices: an interstitial 3D microperfusion system for enhanced viability. J Neurosci Methods. 2009;180:243–54. · DOI · Paper page
  125. Papaspyropoulos A, Tsolaki M, Foroglou N, Pantazaki AA. Modeling and targeting Alzheimer’s disease with organoids. Front Pharm. 2020;11:396. · DOI
  126. Rose MR, Evolutionary biology of aging. Oxford University Press, Oxford 1991.
  127. Aspinall R In: R Aspinall e. Aging of the Organs And Systems. Dordrecht: Springer 2003;3. · DOI
  128. Giaimo S, Traulsen A. The selection force weakens with age because ageing evolves and not vice versa. Nat Commun. 2022;13:686. · doi:10.1038/s41467-022-28254-3
  129. Nie C, Li Y, Li R, Yan Y, Zhang D, Li T, et al. Distinct biological ages of organs and systems identified from a multi-omics study. Cell Rep. 2022;38:110459. · DOI · Paper page
  130. Bellantuono I, de Cabo R, Ehninger D, Di Germanio C, Lawrie A, Miller J, et al. A toolbox for the longitudinal assessment of healthspan in aging mice. Nat Protoc. 2020;15:540–74. · DOI · Paper page
  131. Freund A. Untangling aging using dynamic, organism-level phenotypic networks. Cell Syst. 2019;8:172–81. · DOI
  132. Xie K, Fuchs H, Scifo E, Liu D, Aziz A, Aguilar-Pimentel JA et al. Deep Phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J Mice. bioRxiv 2022: 2022.2003.2025.485824. · DOI
  133. Hall H, Cooper BR, Qi G, Wijeratne AB, Mosley AL, Weake VM. Quantitative proteomic and metabolomic profiling reveals altered mitochondrial metabolism and folate biosynthesis pathways in the aging drosophila eye. Mol Cell Proteom. 2021;20:100127. · DOI
  134. Bajgiran M, Azlan A, Shamsuddin S, Azzam G, Halim MA. Data on RNA-seq analysis of Drosophila melanogaster during ageing. Data Brief. 2021;38:107413. · DOI
  135. Pacifico R, MacMullen CM, Walkinshaw E, Zhang X, Davis RL. Brain transcriptome changes in the aging Drosophila melanogaster accompany olfactory memory performance deficits. PLoS One. 2018;13:e0209405. · DOI
  136. Mangleburg CG, Wu T, Yalamanchili HK, Guo C, Hsieh YC, Duong DM, et al. Integrated analysis of the aging brain transcriptome and proteome in tauopathy. Mol Neurodegener. 2020;15:56. · DOI · Paper page
  137. Brown CJ, Kaufman T, Trinidad JC, Clemmer DE. Proteome changes in the aging Drosophila melanogaster head. Int J Mass Spectrom. 2018;425:36–46. · DOI
  138. Yang L, Cao Y, Zhao J, Fang Y, Liu N, Zhang Y. Multidimensional proteomics identifies declines in protein homeostasis and mitochondria as early signals for normal aging and age-associated disease in Drosophila. Mol Cell Proteom. 2019;18:2078–88. · DOI
  139. Laye MJ, Tran V, Jones DP, Kapahi P, Promislow DE. The effects of age and dietary restriction on the tissue-specific metabolome of Drosophila. Aging Cell. 2015;14:797–808. · DOI · Paper page
  140. Hoffman JM, Soltow QA, Li S, Sidik A, Jones DP, Promislow DE. Effects of age, sex, and genotype on high-sensitivity metabolomic profiles in the fruit fly, Drosophila melanogaster. Aging Cell. 2014;13:596–604. · DOI
  141. Behnke JA, Ye C, Moberg KH, Zheng JQ. A protocol to detect neurodegeneration in Drosophila melanogaster whole-brain mounts using advanced microscopy. STAR Protoc. 2021;2:100689. · DOI
  142. Tamura T, Chiang AS, Ito N, Liu HP, Horiuchi J, Tully T, et al. Aging specifically impairs amnesiac-dependent memory in Drosophila. Neuron. 2003;40:1003–11. · DOI · Paper page
  143. Tonoki A, Davis RL. Aging impairs intermediate-term behavioral memory by disrupting the dorsal paired medial neuron memory trace. Proc Natl Acad Sci. 2012;109:6319–24. · DOI
  144. Saitoe M, Saeki S, Hirano Y, Horiuchi J, Age-related memory impairment inDrosophila. In: Dubnau J (ed). Behavioral Genetics of the Fly (Drosophila Melanogaster). Cambridge University Press: Cambridge, 2014, 177-82. · doi:10.1017/cbo9780511920585.014
  145. Jones MA, Grotewiel M. Drosophila as a model for age-related impairment in locomotor and other behaviors. Exp Gerontol. 2011;46:320–5. · DOI
  146. Iliadi KG, Boulianne GL. Age-related behavioral changes in Drosophila. Ann N. Y Acad Sci. 2010;1197:9–18. · DOI
  147. Giebultowicz JM, Long DM. Aging and circadian rhythms. Curr Opin Insect Sci. 2015;7:82–86. · DOI
  148. Brown MK, Chan MT, Zimmerman JE, Pack AI, Jackson NE, Naidoo N. Aging induced endoplasmic reticulum stress alters sleep and sleep homeostasis. Neurobiol Aging. 2014;35:1431–41. · DOI
  149. Miller MS, Lekkas P, Braddock JM, Farman GP, Ballif BA, Irving TC, et al. Aging enhances indirect flight muscle fiber performance yet decreases flight ability in Drosophila. Biophys J. 2008;95:2391–401. · DOI
  150. Wessells RJ, Bodmer R. Cardiac aging. Semin Cell Dev Biol. 2007;18:111–6. · DOI
  151. Ocorr K, Akasaka T, Bodmer R. Age-related cardiac disease model of Drosophila. Mech Ageing Dev. 2007;128:112–6. · DOI
  152. Tarkhov AE, Alla R, Ayyadevara S, Pyatnitskiy M, Menshikov LI, Shmookler Reis RJ, et al. A universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories. Sci Rep. 2019;9:7368. · DOI · Paper page
  153. Kaletsky R, Murphy CT. Transcriptional Profiling of C. elegans Adult Cells and Tissues with Age. Methods Mol Biol. 2020;2144:177–86. · DOI
  154. Kaletsky R, Yao V, Williams A, Runnels AM, Tadych A, Zhou S, et al. Transcriptome analysis of adult Caenorhabditis elegans cells reveals tissue-specific gene and isoform expression. PLoS Genet. 2018;14:e1007559. · DOI · Paper page
  155. Yasuda K, Ishii T, Suda H, Akatsuka A, Hartman PS, Goto S, et al. Age-related changes of mitochondrial structure and function in Caenorhabditis elegans. Mech Ageing Dev. 2006;127:763–70. · DOI
  156. Pickett CL, Dietrich N, Chen J, Xiong C, Kornfeld K. Mated progeny production is a biomarker of aging in Caenorhabditis elegans. G3. 2013;3:2219–32. · DOI
  157. McGee MD, Day N, Graham J, Melov S. cep-1/p53-dependent dysplastic pathology of the aging C. elegans gonad. Aging. 2012;4:256–69. · DOI
  158. Scharf A, Pohl F, Egan BM, Kocsisova Z, Kornfeld K, Reproductive aging in caenorhabditis elegans: from molecules to ecology. Front. Cell Dev Biol. 2021;9. · DOI
  159. Glenn CF, Chow DK, David L, Cooke CA, Gami MS, Iser WB, et al. Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty. J Gerontol A Biol Sci Med Sci. 2004;59:1251–60. · DOI · Paper page
  160. Chow DK, Glenn CF, Johnston JL, Goldberg IG, Wolkow CA. Sarcopenia in the Caenorhabditis elegans pharynx correlates with muscle contraction rate over lifespan. Exp Gerontol. 2006;41:252–60. · DOI
  161. Pan CL, Peng CY, Chen CH, McIntire S. Genetic analysis of age-dependent defects of the Caenorhabditis elegans touch receptor neurons. Proc Natl Acad Sci USA. 2011;108:9274–9. · DOI · Paper page
  162. Tank EM, Rodgers KE, Kenyon C. Spontaneous age-related neurite branching in Caenorhabditis elegans. J Neurosci. 2011;31:9279–88. · DOI · Paper page
  163. Toth ML, Melentijevic I, Shah L, Bhatia A, Lu K, Talwar A, et al. Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. J Neurosci. 2012;32:8778–90. · DOI · Paper page
  164. Hahm JH, Kim S, DiLoreto R, Shi C, Lee SJ, Murphy CT, et al. C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation. Nat Commun. 2015;6:8919. · DOI · Paper page
  165. Hsu AL, Feng Z, Hsieh MY, Xu XZ. Identification by machine vision of the rate of motor activity decline as a lifespan predictor in C. elegans. Neurobiol Aging. 2009;30:1498–503. · DOI
  166. Kauffman AL, Ashraf JM, Corces-Zimmerman MR, Landis JN, Murphy CT. Insulin signaling and dietary restriction differentially influence the decline of learning and memory with age. PLoS Biol. 2010;8:e1000372. · DOI · Paper page
  167. Son HG, Altintas O, Kim EJE, Kwon S, Lee SV. Age-dependent changes and biomarkers of aging in Caenorhabditis elegans. Aging Cell. 2019;18:e12853. · DOI · Paper page
  168. Mészáros L, Hoffmann A, Wihan J, Winkler J. Current symptomatic and disease-modifying treatments in multiple system atrophy. Int J Mol Sci. 2020;21:2775. · DOI
  169. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Disco. 2010;9:560–74. · DOI · Paper page
  170. Cummings J, Fox N. Defining disease-modifying therapy for Alzheimer’s disease. J Prev Alzheimers Dis. 2017;4:109–15.
  171. Symptomatic vs. Disease-modifying therapies. In: Espay A, Stecher B (eds). Brain Fables: The Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer Them. Cambridge University Press: Cambridge, 2020, 87–94. · DOI
  172. Richardson AM, R. Mechanism of food restriction: change of rate or change of set point. in The potential for nutritional modulation of aging processes (eds Ingram, DK, Baker, GT & Shock, NW) (Food & Nutrition Press) 1992:177–92.
  173. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33. · DOI · Paper page
  174. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA. 1997;94:13215–20. · DOI · Paper page
  175. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA. 2001;98:6736–41. · DOI · Paper page
  176. Dawlaty M, Baker D, Malureanu L, Jeganathan K, van Deursen J. BubR1 overexpression protects against tumorigenesis in mice. Cancer Res. 2008;68:LB-263–LB-263.
  177. Qian Y, Berryman DE, Basu R, List EO, Okada S, Young JA, et al. Mice with gene alterations in the GH and IGF family. Pituitary 2022;25:1–51 https://doi.org/10.1007/s11102-021-01191-y. · DOI

Cited by

See all 118

Metadata

Authors
Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D.
Venue
Molecular Psychiatry
Published
2022-07-15
Volume
28
Issue
1
Pages
242-255
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4285490897
Cited by
118
References
43
FWCI
6.32
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
Helmholtz Association (AMPro)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction? https://app.cochat.ai/papers/10.1038/s41380-022-01680-x
The paper
Keshavarz, M., Xie, K., Schaaf, K., Bano, D., & Ehninger, D. (2023). Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction? Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01680-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.